FDA to Require Additional Info From Importers Affected by Tianjin Port Explosion

The Food and Drug Administration will require extra documentation from importers of food, drugs and medical devices that have passed through the port of Tianjin, China due to a recent industrial accident that resulted in the release of toxic chemicals.

Entry and shipping documents such as bills of lading, air waybills and commercial invoices must be submitted to FDA for any entries of human and animal food products, human and animal drug products, and medical devices that are indicated as having originated from, stored in, or transited through the industrial center Binhai New Area in Tianjin, China.